Lantheus Holdings, Inc. — Investor Relations & Filings
Filings indexed
1,029
across all filing types
Latest filing
2026-02-05
Major Shareholding Noti…
Country
US
United States of America
Listing
US
LNTH
Lantheus Holdings, Inc. is a leading company focused on radiopharmaceuticals, specializing in the development, manufacturing, and commercialization of precision diagnostic and therapeutic products. Its portfolio is designed to assist clinicians in the diagnosis, treatment, and monitoring of various diseases. The company provides diagnostic imaging agents, targeted radiotherapeutics, and leverages artificial intelligence solutions to enhance clinical decision-making. Lantheus's strategy is centered on a 'Find, Fight, and Follow' approach to patient care, aiming to improve outcomes by delivering critical information throughout the disease management process.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-05 | English | |
| Regulatory Filings 2026 | 2026-01-06 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-12-17 | English | |
| Regulatory Filings 2025 | 2025-12-12 | English | |
| Regulatory Filings 2025 | 2025-11-26 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-19 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 30324242 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 12457359 | Regulatory Filings 2026 | 2026-01-06 | English | ||
|
2025
13 filings
| |||||
| 12457360 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-12-17 | English | ||
| 12457361 | Regulatory Filings 2025 | 2025-12-12 | English | ||
| 12457363 | Regulatory Filings 2025 | 2025-11-26 | English | ||
| 12457362 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-19 | English | ||
| 12457365 | Regulatory Filings 2025 | 2025-11-14 | English | ||
| 12457364 | 8-K | 2025-11-12 | English | ||
| 12457366 | Major Shareholding Notification 2025 | 2025-11-12 | English | ||
| 12457367 | 10-Q | 2025-11-06 | English | ||
| 12457368 | 8-K | 2025-11-06 | English | ||
| 12457370 | Major Shareholding Notification 2025 | 2025-11-05 | English | ||
| 12457369 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-09-03 | English | ||
| 12457371 | Director's Dealing 2025 | 2025-08-21 | English | ||
| 12457372 | Director's Dealing 2025 | 2025-08-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Lantheus Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31275/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31275 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31275 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31275 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31275}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lantheus Holdings, Inc. (id: 31275)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.